Class IIOngoing

Sensipar (cinacalcet) Tablets recall

FDA recall D-0614-2026 · initiated Jun 4, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 1, 2026How we research

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations

Details

Product: Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Recalling company: Amgen
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide within the United States
Initiated: Jun 4, 2026
FDA report date: Jul 1, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0614-2026 ↗

← All drug recalls